Knowledge of Genotypic Resistance Mutations Among Providers of Care to Patients with Human Immunodeficiency Virus

Salama, Carlos; Policar, Maurice; Cervera, Christina
January 2003
Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, p101
Academic Journal
Analyzes clinicians' knowledge of genotypic resistance mutations in human immunodeficiency viruses. Percentage of respondents who identified at least one mutation for each of more than equal to four drug groups listed; Respondent percentage that could not match any mutation with any of the drug groups; Care providers among whom knowledge was most deficient.


Related Articles

  • CORRESPONDENCE. Frater, John; Dunn, David; Weber, Jonathan N.; McClure, Myra O.; Perno, Carlo-Federico; Cozzi-Lepri, Alessandro; Balotta, Claudia; Monforte, Antonella d'Arminio // Journal of Infectious Diseases;5/1/2002, Vol. 185 Issue 9, p1376 

    Comments on a study on the association between secondary mutations in human immunodeficiency virus Type 1 protease and therapeutic outcome. Virologic and immunologic responses; Sequencing of virus isolates.

  • HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. Nascimento-Brito, Sieberth; Paulo Zukurov, Jean; Maricato, Juliana T.; Volpini, Angela C.; Salim, Anna Christina M.; Araújo, Flávio M. G.; Coimbra, Roney S.; Oliveira, Guilherme C.; Antoneli, Fernando; Janini, Luiz Mário R. // PLoS ONE;9/28/2015, Vol. 10 Issue 9, p1 

    In order to establish new infections HIV-1 particles need to attach to receptors expressed on the cellular surface. HIV-1 particles interact with a cell membrane receptor known as CD4 and subsequently with another cell membrane molecule known as a co-receptor. Two major different co-receptors...

  • Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy. Perno, Carlo F.; Cozzi-Lepri, Alessandro; Balotta, Claudia; Forbici, Federica; Violin, Michela; Bertoli, Ada; Facchi, Guido; Pezzotti, Patrizio; Cadeo, Gianpiero; Tositti, Giulio; Pasquinucci, Sandro; Pauluzzi, Sergio; Scalzini, Alfredo; Salassa, Bernardino; Vincenti, Antonella; Phillips, Andrew N.; Dianzani, Ferdinando; Appice, Amelia; Angarano, Gioacchino // Journal of Infectious Diseases;10/15/2001, Vol. 184 Issue 8, p983 

    The role of mutations in protease (PR) and reverse-transcriptase (RT) of human immunodeficiency virus (HIV) in predicting virologic failure was assessed in 248 antiretroviral-naive HIV-positive patients who began a PR inhibitor—containing antiretroviral regimen. Genotypic testing was...

  • GMC warns doctors infected with HIV or suffering from AIDS.  // British Medical Journal (Clinical Research Edition);12/5/1987, Vol. 295 Issue 6611, p1500 

    Focuses on practicing doctors infected with human immunodeficiency virus (HIV) in Great Britain. Impact of the issue on patients and the public; Reaction from the General Medical Council; Statements from the council regarding duties of doctors to patients.

  • `Dear patients: This is a most difficult letter to write' Ferguson, J. Scott // Medical Economics;3/25/96, Vol. 73 Issue 6, p44 

    Opinion. Relates an experience of a physician writing a letter to his patients and colleagues informing them of his diagnosis of being HIV-positive. How did this diagnosis affect the doctor and his family; Background information on the doctor's life; What were the responses of the patients.

  • Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity. Abdurahman, Samir; Höglund, Stefan; Höglund, Anders; Vahlne, Anders // Retrovirology;2007, Vol. 4, p19 

    We have studied the effects associated with two single amino acid substitution mutations in HIV-1 capsid (CA), the E98A and E187G. Both amino acids are well conserved among all major HIV-1 subtypes. HIV-1 infectivity is critically dependent on proper CA cone formation and mutations in CA are...

  • Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity. Abdurahman, Samir; Youssefi, Masoud; Höglund, Stefan; Vahlne, Anders // Retrovirology;2007, Vol. 4, p69 

    Background: The mature HIV-1 conical core formation proceeds through highly regulated protease cleavage of the Gag precursor, which ultimately leads to substantial rearrangements of the capsid (CAp24) molecule involving both inter- and intra-molecular contacts of the CAp24 molecules. In this...

  • Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report. Yudong Quan; Brenner, Bluma G.; Dascal, André; Wainberg, Mark A. // Retrovirology;2008, Vol. 5, Special section p1 

    Background: Although drug resistance is a major challenge in HIV therapy, the effect of drug resistance mutations on HIV evolution in vivo is not well understood. We have now investigated genetic heterogeneity in HIV-1 by performing drug resistance genotyping of the PR-RT regions of viruses...

  • Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients. Re, Maria Carla; Monari, Paola; Bon, Isabella; Gibellini, Davide; Vitone, Francesca; Borderi, Marco; La Placa, Michele // BMC Microbiology;2001, Vol. 1, p30 

    Background: The routine determination of drug resistance in newly HIV-1 infected individuals documents a potential increase in the transmission of drug-resistant variants. Plasma samples from twenty seven therapy naive HIV-1 infected Italian patients were analyzed by the line probe assay (LIPA)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics